Glaucocalyxin A Induces Cytotoxicity in Renal Cancer Cells via ROS-Mediated Autophagy by Direct Targeting of

Yaping Niu1, Jinhuan Ou2, Xiaoru Zhong2

  • 1School of Pharmaceutical Sciences, National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine, Nanchang, 330004, China.

Advanced Biology
|October 1, 2025
PubMed

Insights

Glaucocalyxin A (GLA) kills renal cell carcinoma (RCC) cells by increasing reactive oxygen species (ROS), activating a pro-death autophagy pathway. Researchers identified PRDX1/2 proteins as GLA targets, revealing a new therapeutic approach for RCC.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Glaucocalyxin A (GLA), a diterpenoid from Rabdosia japonica, shows antitumor potential.
  • The precise molecular mechanisms of GLA in renal cell carcinoma (RCC) are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying GLA's cytotoxicity in RCC.
  • To identify the direct molecular targets of GLA in RCC cells.

Main Methods:

  • Utilized activity-based protein profiling (ABPP) and proteomic analysis to identify GLA targets.
  • Investigated the roles of reactive oxygen species (ROS) and autophagy in GLA-induced cytotoxicity.
  • Performed functional validation of identified targets, including PRDX1/2, in RCC cells.

Main Results:

  • GLA induces cytotoxicity in RCC cells via overaccumulation of reactive oxygen species (ROS).
  • ROS surge activates autophagy, which acts as a crucial effector in GLA-induced cell death.
  • Peroxiredoxins PRDX1 and PRDX2 were identified as direct covalent targets of GLA.
  • Overexpression of PRDX1/2 confers resistance to GLA-induced apoptosis, highlighting their role in redox sensing.

Conclusions:

  • GLA triggers a cascade involving ROS accumulation, autophagy activation, and apoptosis in RCC cells.
  • PRDX1/2 are critical targets and redox sensors that mediate GLA's cytotoxic effects.
  • GLA represents a promising therapeutic scaffold for developing novel treatments for renal cell carcinoma.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K